|
|
Volumn 18, Issue , 1996, Pages 202-214
|
|
Chemical, pharmacological, toxicological and therapeutic advances of deferiprone (L1) and other iron and aluminium chelators.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALUMINUM;
CHELATING AGENT;
DEFERIPRONE;
IRON;
IRON CHELATING AGENT;
PYRIDONE DERIVATIVE;
ANIMAL;
BIOTRANSFORMATION;
DRUG DESIGN;
DRUG EFFECT;
HUMAN;
INTOXICATION;
MOUSE;
PHARMACOKINETICS;
PRENATAL DEVELOPMENT;
RABBIT;
RAT;
REVIEW;
STRUCTURE ACTIVITY RELATION;
ALUMINUM;
ANIMALS;
BIOTRANSFORMATION;
CHELATING AGENTS;
DRUG DESIGN;
EMBRYONIC AND FETAL DEVELOPMENT;
HUMANS;
IRON;
IRON CHELATING AGENTS;
MICE;
POISONING;
PYRIDONES;
RABBITS;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
THERAPEUTIC EQUIVALENCY;
MLCS;
MLOWN;
|
|
EID: 0029686654
PISSN: 01719750
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-61105-6_21 Document Type: Review |
|
Times cited : (7)
|
|
References (56)
|
